ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 97 filers reported holding ONCOCYTE CORP in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,000 | -27.3% | 5,296 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -42.1% | 5,296 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $19,000 | -36.7% | 5,296 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $30,000 | +11.1% | 5,296 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $27,000 | +107.7% | 5,296 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $13,000 | +333.3% | 5,296 | +179.3% | 0.00% | – |
| Q3 2020 | $3,000 | -25.0% | 1,896 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | -20.0% | 1,896 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | +25.0% | 1,896 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | 0.0% | 1,896 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 1,896 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | +400.0% | 1,896 | +500.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 316 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | – | 316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 23,353,697 | $17,048,000 | 1.30% |
| AWM Investment Company, Inc. | 7,746,557 | $5,655,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 18,056,274 | $13,181,000 | 0.76% |
| Defender Capital, LLC. | 2,551,980 | $1,883,000 | 0.74% |
| Penbrook Management LLC | 563,350 | $411,000 | 0.35% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $241,000 | 0.33% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $55,000 | 0.04% |
| Fort Sheridan Advisors LLC | 135,000 | $99,000 | 0.03% |
| Orbimed Advisors | 1,882,768 | $1,374,000 | 0.03% |
| WEALTH EFFECTS LLC | 51,000 | $37,000 | 0.02% |